Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Tempest Therapeutics Inc. sell me8

Tempest Therapeutics Inc.
Start price
€35.61
12.07.21 / 0%
Target price
€25.00
12.07.22
Performance (%)
-50.33%
End price
€17.69
13.07.21
Summary
This prediction ended on 13.07.21 with a price of €17.69. The SELL prediction by me8 for Tempest Therapeutics Inc. performed very well with a performance of -50.33%. This prediction was marked as speculative and is excluded from me8's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
Tempest Therapeutics Inc. 3.758% 3.758% 85.081%
iShares Core DAX® -0.922% -1.993% 13.399%
iShares Nasdaq 100 0.371% -0.868% 41.541%
iShares Nikkei 225® 2.224% -5.187% 20.497%
iShares S&P 500 -0.026% -0.918% 30.410%

According to me8 what are the pros and cons of Tempest Therapeutics Inc. for the foreseeable future?

Pros
Capable Management
Good culture
Cons
No Innovation
Risky Investment

Comments by me8 for this prediction

In the thread Tempest Therapeutics Inc. diskutieren

Sell Tempest Therapeutics Inc.

me8 
0
Report Share
12.07.21 Sell -50.33%
Prediction Sell
Perf. (%) -50.33%
Target price 25.000
Change
Ends at 12.07.22

Kursziel gesetzt auf 25,0

me8 
0
Report Share
12.07.21
In the thread Trading Tempest Therapeutics Inc.
Prediction Sell
Perf. (%) -50.33%
Target price 25.000
Change
Ends at 12.07.22

Sell beendet

me8 
0
Report Share
13.07.21

Stopped prediction by me8 for Tempest Therapeutics Inc.

sell
Tempest Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.96
16.10.23
-
16.10.24
-21.77%
28.10.23

Capable Management
Good culture
No Innovation
Risky Investment
me8 
16.10.23 0%